Cargando…

Hand grip strength in venous thromboembolism: risk of recurrence and mortality

BACKGROUND: There is limited information on the relationship between muscle strength and recurrence and mortality after incident venous thromboembolism (VTE). OBJECTIVES: To investigate whether weak hand grip strength (HGS) was associated with risk of recurrence and mortality in patients with VTE re...

Descripción completa

Detalles Bibliográficos
Autores principales: Leknessund, Oda G.R., Morelli, Vania M., Hansen, John-Bjarne, Brækkan, Sigrid K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10439395/
https://www.ncbi.nlm.nih.gov/pubmed/37601029
http://dx.doi.org/10.1016/j.rpth.2023.102138
_version_ 1785092933939101696
author Leknessund, Oda G.R.
Morelli, Vania M.
Hansen, John-Bjarne
Brækkan, Sigrid K.
author_facet Leknessund, Oda G.R.
Morelli, Vania M.
Hansen, John-Bjarne
Brækkan, Sigrid K.
author_sort Leknessund, Oda G.R.
collection PubMed
description BACKGROUND: There is limited information on the relationship between muscle strength and recurrence and mortality after incident venous thromboembolism (VTE). OBJECTIVES: To investigate whether weak hand grip strength (HGS) was associated with risk of recurrence and mortality in patients with VTE recruited from the general population. METHODS: Participants from the Tromsø Study with a first-time VTE (n = 545) were included, and all VTE recurrences and deaths among the participants were recorded in the period 1994 to 2020. Weak HGS was defined as lowest 25th percentile of the general population, and incidence rates for VTE recurrence and mortality according to weak vs normal (>25th percentile) HGS, with 95% CIs, were estimated. RESULTS: There were 90 recurrences and 350 deaths during a median of 3.7 years of follow-up. The fully adjusted hazard ratio (HR) for overall VTE recurrence for those with weak HGS vs those with normal HGS was 2.02 (95% CI, 1.23-3.30). The corresponding HRs for recurrence were 2.22 (95% CI, 1.18-4.17) in patients with a first deep vein thrombosis and 1.60 (95% CI, 0.72-3.57) in patients with a first pulmonary embolism. The cumulative 1-year survival was 74.9% and 77.8% in those with weak and normal HGS, respectively. For overall mortality after incident VTE, the fully adjusted HR for those with weak HGS was 1.34 (95% CI, 1.04-1.72). CONCLUSION: Weak HGS was associated with an increased risk of recurrent VTE, and the association appeared to be particularly pronounced after incident deep vein thrombosis. There was a slightly lower survival probability among those with weak HGS than among those with normal HGS.
format Online
Article
Text
id pubmed-10439395
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-104393952023-08-20 Hand grip strength in venous thromboembolism: risk of recurrence and mortality Leknessund, Oda G.R. Morelli, Vania M. Hansen, John-Bjarne Brækkan, Sigrid K. Res Pract Thromb Haemost Original Article BACKGROUND: There is limited information on the relationship between muscle strength and recurrence and mortality after incident venous thromboembolism (VTE). OBJECTIVES: To investigate whether weak hand grip strength (HGS) was associated with risk of recurrence and mortality in patients with VTE recruited from the general population. METHODS: Participants from the Tromsø Study with a first-time VTE (n = 545) were included, and all VTE recurrences and deaths among the participants were recorded in the period 1994 to 2020. Weak HGS was defined as lowest 25th percentile of the general population, and incidence rates for VTE recurrence and mortality according to weak vs normal (>25th percentile) HGS, with 95% CIs, were estimated. RESULTS: There were 90 recurrences and 350 deaths during a median of 3.7 years of follow-up. The fully adjusted hazard ratio (HR) for overall VTE recurrence for those with weak HGS vs those with normal HGS was 2.02 (95% CI, 1.23-3.30). The corresponding HRs for recurrence were 2.22 (95% CI, 1.18-4.17) in patients with a first deep vein thrombosis and 1.60 (95% CI, 0.72-3.57) in patients with a first pulmonary embolism. The cumulative 1-year survival was 74.9% and 77.8% in those with weak and normal HGS, respectively. For overall mortality after incident VTE, the fully adjusted HR for those with weak HGS was 1.34 (95% CI, 1.04-1.72). CONCLUSION: Weak HGS was associated with an increased risk of recurrent VTE, and the association appeared to be particularly pronounced after incident deep vein thrombosis. There was a slightly lower survival probability among those with weak HGS than among those with normal HGS. Elsevier 2023-06-29 /pmc/articles/PMC10439395/ /pubmed/37601029 http://dx.doi.org/10.1016/j.rpth.2023.102138 Text en © 2023 The Author(s) https://creativecommons.org/licenses/by/4.0/This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Original Article
Leknessund, Oda G.R.
Morelli, Vania M.
Hansen, John-Bjarne
Brækkan, Sigrid K.
Hand grip strength in venous thromboembolism: risk of recurrence and mortality
title Hand grip strength in venous thromboembolism: risk of recurrence and mortality
title_full Hand grip strength in venous thromboembolism: risk of recurrence and mortality
title_fullStr Hand grip strength in venous thromboembolism: risk of recurrence and mortality
title_full_unstemmed Hand grip strength in venous thromboembolism: risk of recurrence and mortality
title_short Hand grip strength in venous thromboembolism: risk of recurrence and mortality
title_sort hand grip strength in venous thromboembolism: risk of recurrence and mortality
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10439395/
https://www.ncbi.nlm.nih.gov/pubmed/37601029
http://dx.doi.org/10.1016/j.rpth.2023.102138
work_keys_str_mv AT leknessundodagr handgripstrengthinvenousthromboembolismriskofrecurrenceandmortality
AT morellivaniam handgripstrengthinvenousthromboembolismriskofrecurrenceandmortality
AT hansenjohnbjarne handgripstrengthinvenousthromboembolismriskofrecurrenceandmortality
AT brækkansigridk handgripstrengthinvenousthromboembolismriskofrecurrenceandmortality